Inventor · disambiguated record
Xiang Li
Also filed as: LI XIANG · LI XIANG-YI
33 granted patents·14 pending applications·112 citations·filing 2003–2025
96Inventor score
Files withBEIJING TIDE PHARMACEUTICAL CO LTD14BOEHRINGER INGELHEIM INT8EISAI R&D MAN CO LTD6EISAI CO LTD3BOIVIN ROCH2
Top patents by PatentIndex Score
47 records- 0195US11919918B2P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Mar 5, 2024·6 cites·20 claims
- 0293US11390609B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 19, 2022·12 cites·28 claims
- 0393US10329282B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 25, 2019·13 cites·45 claims
- 0493US10323023B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 18, 2019·14 cites·71 claims
- 0591US12180243B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2022·Granted Dec 31, 2024·2 cites·74 claims
- 0689US11414444B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Aug 16, 2022·5 cites·15 claims
- 0787US9242989B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 26, 2016·4 cites·53 claims
- 0886US11453690B2Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 27, 2022·3 cites·50 claims
- 0985US8937056B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2013·Granted Jan 20, 2015·3 cites·14 claims
- 1084US8329742B2Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2010·Granted Dec 11, 2012·9 cites·32 claims
- 1184US8093266B2Rho kinase inhibitorsDAHMANN GEORG·Filed 2008·Granted Jan 10, 2012·8 cites·11 claims
- 1282US7799827B2Macrocyclic compounds useful as pharmaceuticalsEISAI CO LTD·Filed 2003·Granted Sep 21, 2010·16 cites·30 claims
- 1380US12509479B2P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Granted Dec 30, 2025·0 cites·17 claims
- 1480US10954215B2Compounds as modulators of ROR gammaBOEHRINGER INGELHEIM INT·Filed 2017·Granted Mar 23, 2021·3 cites·8 claims
- 1579US2025066398A1Receptor inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 1676US7314936B2Deazapurines and uses thereofEISAI CO LTD·Filed 2003·Granted Jan 1, 2008·8 cites·34 claims
- 1774US8697911B2Rho kinase inhibitorsCOOK BRIAN NICHOLAS·Filed 2011·Granted Apr 15, 2014·3 cites·12 claims
- 1869US11160783B2Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2018·Granted Nov 2, 2021·0 cites·18 claims
- 1967US11939578B2Double-stranded RNA molecule targeting CKIP-1 and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Granted Mar 26, 2024·0 cites·14 claims
- 2067US8609640B2Multikinase inhibitors for use in the treatment of cancerAGOULNIK SERGEI·Filed 2008·Granted Dec 17, 2013·1 cites·15 claims
- 2165US2019002465A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 2263US8691814B2Deazapurines and uses thereofDAUN JANE·Filed 2010·Granted Apr 8, 2014·1 cites·35 claims
- 2362US11155819B2Double-stranded RNA molecule targeting CKIP-1 and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 26, 2021·0 cites·20 claims
- 2462US9598415B2Compounds as modulators of RORγBOEHRINGER INGELHEIM INT·Filed 2016·Granted Mar 21, 2017·0 cites·33 claims
- 2562US2023030115A1Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2661US7868002B2Deazapurines and uses thereofEISAI R&D MAN CO LTD·Filed 2007·Granted Jan 11, 2011·0 cites·31 claims
- 2760US7524883B2Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2003·Granted Apr 28, 2009·1 cites·52 claims
- 2860US2025339411A1Glp-1r agonist compound and use thereofCHONGQING PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2025·Application pending·0 cites
- 2960US2018022749A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 3059US2015182496A1Multikinase inhibitors for use in the treatment of cancerEISAI R&D MAN CO LTD·Filed 2015·Application pending·0 cites
- 3159US2010093842A1Laulimalide Analogs and Uses ThereofEISAI CO LTD·Filed 2009·Application pending·0 cites
- 3258US12419874B2GLP-1R agonist compound and use thereofCHONGQING PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2025·Granted Sep 23, 2025·0 cites·20 claims
- 3358US2016075706A1Compounds as modulators of ror gammaBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 3456US2009291998A1Eponemycin and epoxomicin analogs and uses thereofEISAI R&D MAN CO LTD·Filed 2009·Application pending·0 cites
- 3554US2024124853A1Transaminase mutants and uses thereofASYMCHEM LAB TIANJIN CO LTD·Filed 2021·Application pending·0 cites
- 3651US2013196987A1Macrocyclic compounds useful as pharmaceuticalsBOIVIN ROCH·Filed 2012·Application pending·0 cites
- 3751US2007287745A1Laulimalide Analogs and Uses ThereofGALLAGHER JR BRIAN M·Filed 2004·Application pending·0 cites
- 3848US11535796B2Quantum dot material, and preparation method and use thereofSHENZHEN PLANCK INNOVATION TECH CO LTD·Filed 2020·Granted Dec 27, 2022·0 cites·15 claims
- 3948US2009197867A1Enantiomerically enriched imidazoazepinone compoundsSPYVEE MARK·Filed 2008·Application pending·0 cites
- 4046US12398118B2Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Aug 26, 2025·0 cites·13 claims
- 4145US9745297B2Compounds as modulators of RORCBOEHRINGER INGELHEIM INT·Filed 2014·Granted Aug 29, 2017·0 cites·13 claims
- 4243US11905274B2Receptor inhibitors, pharmaceutical compositions comprising the same and use thereofBEIJING TIDE PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 20, 2024·0 cites·44 claims
- 4342US9745267B2Compounds as modulators of RORCCOOK BRIAN NICHOLAS·Filed 2014·Granted Aug 29, 2017·0 cites·12 claims
- 4439US10450314B2Pteridine derivatives as modulators of ROR gammaBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 22, 2019·0 cites·9 claims
- 4536US2015322071A1Process for preparing triazole pyrimidine compounds and intermediates thereofBRIGHTGENE BIO MEDICAL TECHNOLOGY SUZHOU CO LTD·Filed 2013·Application pending·0 cites
- 4635US12440572B2FVIII fusion protein and use thereofZHENGZHOU GENSCIENCES INC·Filed 2019·Granted Oct 14, 2025·0 cites·10 claims
- 4729US12501868B2Haploid induction compounds and methods for use thereofWIMI BIOTECHNOLOGY HAINAN CO LTD·Filed 2022·Granted Dec 23, 2025·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Xiang Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →